Cornea/External Disease News

Eyenovia and SGN Nanopharma have announced a collaboration agreement to develop a new drug-device combination product for chronic dry eye disease.

Patients with dry eye disease experienced improvements in ocular discomfort after treatment with reproxalap, according to a press release from Aldeyra Therapeutics.

Over in my column The Dry Eye, I’ve embarked on a project to look at the basics of diagnosing and treating dry eye disease.

OcuSoft announced the launch of Retaine Allergy, a prescription-strength olopatadine hydrochloride ophthalmic solution 0.2% for eye allergy itch relief.

Post-refractive ectasia is very rare. The incidence is only about 0.1% per 100,000 eyes undergoing LASIK and less than that in eyes undergoing PRK or SMILE.

World KC Day, a global event sponsored by the National Keratoconus Foundation to promote awareness of keratoconus, is celebrated annually on Nov. 10.

HCP Cureblindness is rebranding as the Cure Blindness Project, according to a press release.

Many patients with ocular surface disease have sought relief at their hometown pharmacies with long-proven, branded lubricants.

July is Dry Eye Awareness Month, but educating patients about symptoms and treatment is critical throughout the year, especially in light of recent data that show many American adults do not know relief is possible.

Eyenovia and Senju Pharmaceutical Co. have announced a collaboration agreement to develop Senju’s SJP-0035 for use with Eyenovia’s Optejet dispensing technology as a combination product to treat chronic dry eye disease.